In relation with cancer stem cells (CSC), CD90+ cells but not CD90- cells, obtained from HCC cell lines, tumor tissues, and peripheral blood displayed tumorigenic and metastatic capacity when injected into immunodeficient mice [16–18]. The gene discussed is THY1; the disease is cancer.